Allergic conjunctivitis (eye allergies) affects approximately 30% of the US population. People may experience ocular (eye) allergies after exposure to allergens such as dust, pollen, pet dander and other irritants. Typical symptoms include ocular itching, redness, and tearing.
The purpose of this trial is to study the effectiveness and safety of TL-925. TL-925 is a novel eye drop that is designed to suppress the appearance and symptoms of
eye allergies.
Participants will undergo several exams and tests throughout the study to assess their allergen reactions and response to the study medication.
To see if you qualify, complete
the form below. Our team will reach out to ask a few questions and provide more details.
You may qualify to participate if you:
Have a positive skin test reaction, at your first study visit, to a seasonal (eg, grass, ragweed, tree pollen) or perennial (eg, cat dander, dog dander, dust mites, cockroach) allergen.
Have NOT had ocular surgery within the last three months or refractive surgery within the last six months.
Are 18 years or older
*Additional Criteria Will Apply
If you qualify for this study, here is what you can expect:
Study Visits: You will be asked to attend up to 14 study visits over approximately six to eight weeks.
Skin Prick Test: Participants will undergo a Skin Prick Test to check for hypersensitivity, or allergic reaction, to various allergens.
Eye Exams and Medical History Reviews: Participants will need to complete several eye exams and discuss their medical history with study staff.
Allergy Exposure & Study Drug: Participants will be exposed to the allergen identified from their skin prick test followed by the administration of the study medication.
Compensation: You may receive up to $XXX for your time and participation.
The study team will go over all assessments with you in detail during your visit.
We are currently conducting this study at a single location. Check out our clinic location below to find out if our study site is near you.
Add Your Tooltip Text Here
The study will include 14 in-person clinic visits over approximately six to eight weeks. Visits may last between one to four hours.
No. You will have a Skin Prick Test to check for hypersensitivity, or allergic reaction, to seasonal and perennial allergens. This is where a small amount of an allergen is placed on the skin, and the skin is gently pricked. If you commonly experience eye allergies when you are outside or around dust or pets, you may be eligible to participate in this study.
Taking part in any clinical study is entirely voluntary. Your decision whether to participate will not affect the medical care you currently receive or may receive in the future. If you qualify and choose to join the study, you may withdraw at any time and for any reason.
All study-related testing will be provided to you by the sponsor at no charge; Any tests and procedures that are routine care for your eye condition (not part of this research study) may be billed to your insurance.
Your personal and medical information is completely protected before, during and after the clinical trial process through the HIPAA (Health Insurance Portability and Accountability Act) Privacy Rule. You will also be informed of who has access to your personal information.
Key Inclusion Criteria
Key Exclusion Criteria
Sign up for email alerts when new trials and locations are added for a medical condition.